Characteristics, treatment patterns and retention with extended-release subcutaneous buprenorphine for opioid use disorder: A population-based cohort study in Ontario, Canada

Uptake and retention for opioid agonist treatment (OAT) remains low. Novel extended-release formulations may improve OAT accessibility by reducing the frequency of healthcare visits. Our aim was to examine uptake, characteristics, treatment patterns and retention of individuals initiating extended-r...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Drug and alcohol dependence 2024-01, Vol.254, p.111032-111032, Article 111032
Hauptverfasser: Iacono, Anita, Wang, Tianru, Tadrous, Mina, Campbell, Tonya, Kolla, Gillian, Leece, Pamela, Sproule, Beth, Kleinman, Robert A, Besharah, Jes, Munro, Charlotte, Doolittle, McCaffrey, Gomes, Tara
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!